Research theme for competitive and other funds (2)：
2022 - 2025 骨格筋由来エクソソームによるサルコペニア合併敗血症増悪機序の解明
2018 - 2021 Strategy for the treatment of CKD-induced sarcopenia based on the crosstalk between myokine and uremic toxins
Papers (91)：
Keisuke Takada, Yuki Enoki, Masaru Samura, Yuki Igarashi, Kazuaki Taguchi, Koji Tanikawa, Kazuaki Matsumoto. Influence factors of metronidazole-related CNS disorders: an analysis of the Japan adverse drug event report and FDA adverse event reporting system. Expert Opinion on Drug Safety. 2025. 1-7
Tomoyuki Ishigo, Kazuaki Matsumoto, Hiroaki Yoshida, Hiroaki Tanaka, Yuta Ibe, Satoshi Fujii, Masahide Fukudo, Hisato Fujihara, Fumihiro Yamaguchi, Fumiya Ebihara, et al. Reply to Mitsuboshi, "Enhancing result reliability by addressing potential confounding factors". Microbiology spectrum. 2025. e0149924
Yuki Hanai, Kazuaki Matsumoto, Aiju Endo, Kazumi Hanawa, Hideki Hashi, Taito Miyazaki, Tetsuo Yamaguchi, Sohei Harada, Takuya Yokoo, Shusuke Uekusa, et al. Treatment success prediction in patients with methicillin-resistant coagulase-negative staphylococci infections, using vancomycin AUC24/MIC ratio: a multicentre retrospective cohort study. The Journal of antimicrobial chemotherapy. 2024
Yuto Suzuki, Yo Arakida, Hiromi Sakai, Yuki Enoki, Kazuaki Matsumoto, Kazuaki Taguchi. Elucidating the binding properties of methemoglobin in red blood cell to cyanide, hydrosulfide, and azide ions using artificial red blood cell. Toxicology and Applied Pharmacology. 2023. 116752-116752
Sumika Osa, Yuki Enoki, Taichi Miyajima, Masahiro Akiyama, Yukio Fujiwara, Kazuaki Taguchi, Yun Gi Kim, Kazuaki Matsumoto. SCIATIC DENERVATION-INDUCED SKELETAL MUSCLE ATROPHY IS ASSOCIATED WITH PERSISTENT INFLAMMATION AND INCREASED MORTALITY DURING SEPSIS. Shock. 2023. 59. 3. 417-425
